🇺🇸 FDA
Pipeline program

Imdusiran, IMFINZI 50 mg/mL concentrate for solution for infusion.

AB-729-203

Phase 2 small_molecule active

Quick answer

Imdusiran, IMFINZI 50 mg/mL concentrate for solution for infusion. for Chronic HBV Infection is a Phase 2 program (small_molecule) at Arbutus Biopharma Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Arbutus Biopharma Corp
Indication
Chronic HBV Infection
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials